Avaliação dos efeitos do resveratrol sobre o tecido ósseo de ratas ovariectomizadas

Abstract

Resveratrol (trans 3,5,4 'trihydroxystilbene) is a polyphenol found in some plants and fruits. There are indications that it may be associated with the prevention of osteoporosis due to its action similar to a SERM (Selective Estrogen Receptor Modulators), a substance used to treat osteoporosis (among other diseases) in women whose use of hormone replacement therapy does not is indicated. However, more specific information about their effect in various quotas of bone tissue is still scarce. The aim of this study was to evaluate the ability of resveratrol to protect against bone changes characteristics of estrogen deficit in young adult ovariectomized rats. Were utilized 30 animals (Wistar rats) distributed into 3 groups: intact group (INT) with 10 intact animals, ovariectomized group (OVX) with 10 ovariectomized animals treated with a saline and dimethylsulfoxide (DMSO) solution, ovariectomized + resveratrol group (OVX + RES) with 10 ovariectomized animals treated with a resveratrol, saline and DMSO solution [0.7 mg/kg BW (body weight)], 7 times a week, for 12 weeks. Biometric, biophysical, biomechanical, microtomographical and radiographic density parameters were analyzed from bones with higher cortical (femur) and trabecular quota (vertebrae). The biomechanical properties of femurs were obtained by the three-point bending test and the lumbar vertebrae obtained by bone compression test. Lumbar vertebrae were used to perform the microtomographical analysis and radiographic density analysis. The ovariectomized rats gained more body weight and had lower bone density and radiographic density, and also showed reduction of microtomographical parameters when compared to the intact group. The biomechanical parameters of femurs did not change in neither group. The animals treated with resveratrol did not shown decrease in microtomographical parameters and bone density of the vertebrae as the untreated group. Therefore, the results suggest resveratrol as a potential protector of ovariectomy induced spoliation of bone tissues with greater trabecular quota.